Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p16 and p53 Protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Nov 2002

Geisler Stacy A, Olshan Andrew F, Weissler Mark C, Cai Jainwen, Funkhouser William K, Smith Joanna, Vick Katie

Abstract excerpt

PURPOSE: Markers of somatic mutation such as p16 and p53 remain controversial prognostic indicators for patients with squamous cell carcinoma of the head and neck (SCCHN). The relationship between p53 protein expression and radiation therapy is also unclear. EXPERIMENTAL DESIGN: We made a prospective cohort study (n = 171) of incident cases receiving standardized therapy for SCCHN. RESULTS: Patients whose tumors...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cohort Studies
Share to Cyclin-Dependent Kinase Inhibitor p16

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Head and Neck Neoplasms

Share to Immunohistochemistry

Share to Loss of Heterozygosity

Share to Proportional Hazards Models

Share to Recurrence

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 12429633

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p16 and p53 Protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer.PMID 12429633Read ↗

p16 mutation frequency and clinical correlation in head and neck cancer.Semantic proximity Read ↗

Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis.Semantic proximity Read ↗

p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Human papillomavirus genotype and oropharynx cancer survival in the United States of America.Semantic proximity Read ↗

Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population.Semantic proximity Read ↗

Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.Semantic proximity Read ↗

Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Prognostic Role of p16 Overexpression in Sinonasal Squamous Cell Carcinoma: A Retrospective Analysis of Alberta PatientsSemantic proximity Read ↗

Effective Biomarkers and Radiation Treatment in Head and Neck Cancer.Semantic proximity Read ↗

Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.Semantic proximity Read ↗

Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.Semantic proximity Read ↗

Human papillomavirus infection and p53 mutation in esophageal squamous cell carcinoma and its impact on treatment outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.